Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04876456
Title A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nabil Adra
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin & Bren Simon Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field